Guardant Health, Inc.
GH
$161.99
$9.646.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.26% | -17.78% | -15.75% | 13.95% | 2.66% |
| Total Depreciation and Amortization | -4.79% | -7.76% | -3.86% | -11.23% | -5.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.63% | 32.28% | 53.79% | -12.44% | -3.65% |
| Change in Net Operating Assets | 29.55% | 0.29% | 1,240.22% | 74.26% | 62.30% |
| Cash from Operations | 4.16% | -4.68% | 59.12% | 30.64% | 35.87% |
| Capital Expenditure | -108.16% | -25.14% | -47.54% | -146.49% | -11.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,364.64% | 129.40% | -2,882.63% | 98.62% | -- |
| Cash from Investing | 1,052.89% | 130.93% | -8,695.13% | 95.13% | -109.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 206.25% | 375.39% | 7,139.65% | 18,505.00% | -3.54% |
| Repurchase of Common Stock | -12.10% | 65.87% | 33.29% | 21.19% | -129.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,685.94% | 35.62% | -41,069.49% | -6,851.61% | 56.16% |
| Cash from Financing | 1,317.12% | 67.72% | 25,041.33% | 250.12% | -72.47% |
| Foreign Exchange rate Adjustments | -143.86% | -125.10% | 59.53% | -128.05% | 211.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 196.97% | 251.54% | -241.39% | 86.75% | 27.28% |